Detalhe da pesquisa
1.
Correlation between susceptibility of primary HIV-1 isolates to autologous and heterologous neutralizing antibodies. Hospital Evandro Chagas AIDS Clinical Research Group.
AIDS
; 11(8): 969-75, 1997 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-9223730
2.
Anti-HIV-1 seroreactivity and HIV transmission route[R1]. The HEC/FIOCRUZ AIDS Clinical Research Group.
J Clin Virol
; 12(1): 27-36, 1999 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-10073411
3.
Neutralization susceptibility of B subtype variant B" primary HIV-1 isolates. The HEC/FIOCRUZ AIDS Clinical Research Group.
Scand J Immunol
; 47(6): 603-8, 1998 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-9652830
4.
Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.
Scand J Immunol
; 53(3): 302-9, 2001 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-11251889
5.
HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group.
Mem Inst Oswaldo Cruz
; 93(3): 391-8, 1998.
Artigo
Inglês
| MEDLINE | ID: mdl-9698875
6.
Neutralization of primary HIV-1 isolated from individuals residing in Rio de Janeiro. HEC/FIOCRUZ AIDS Clinical Research Group.
Mem Inst Oswaldo Cruz
; 91(3): 343-5, 1996.
Artigo
Inglês
| MEDLINE | ID: mdl-9040852
7.
HIV specific humoral immune response in Rio de Janeiro, Brazil
Mem. Inst. Oswaldo Cruz
; 93(3): 391-8, May-Jun. 1998. tab, graf
Artigo
Inglês
| LILACS | ID: lil-209963
8.
Neutralization of primary HIV-1 isolated from individuals residing in Rio de Janeiro. HEC/FIOCRUZ AIDS Clinical Research Group
Mem. Inst. Oswaldo Cruz
; 91(3): 343-345, May-Jun. 1996.
Artigo
Inglês
| LILACS | ID: lil-319866